Leah Anderson, PA | |
1415 Lilac Dr N Ste 190, Golden Valley, MN 55422-4544 | |
(763) 267-8701 | |
Not Available |
Full Name | Leah Anderson |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 1415 Lilac Dr N Ste 190, Golden Valley, Minnesota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861147332 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Leah Anderson, PA 1415 Lilac Dr N Ste 190, Golden Valley, MN 55422-4544 Ph: (763) 267-8701 | Leah Anderson, PA 1415 Lilac Dr N Ste 190, Golden Valley, MN 55422-4544 Ph: (763) 267-8701 |
News Archive
Patients with a very high blood pressure reading in the absence of other symptoms are highly unlikely to have a major adverse cardiovascular event within the next 6 months, researchers report.
During the COVID-19 pandemic, most science and medical faculty began working from home, with women reporting a significant decrease in manuscript submissions.
Researchers in the School of Medicine at the University of California, Riverside have identified an immune protein in mice that is quickly triggered in the body following infection and serves to protect the body's tissues. Called "RELMalpha," this protein, whose homologue in humans is called "resistin," is responsible more for protecting the body than attacking the parasite.
Cell Therapeutics, Inc. ("CTI") announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology ("ASH") Annual Meeting updated results from the pivotal phase III EXTEND (PIX 301) clinical trial of pixantrone (the "PIX 301 EXTEND trial") in relapsed or refractory, aggressive non-Hodgkin's lymphoma ("NHL") patients who have failed 2 or more prior therapies.
› Verified 5 days ago